Company research
XTL BIOPHARMACEUTICALS LTD
CIK 1023549Updated Sep 24, 2026
SecurityXTLB · NASDAQ · adr
XTLB price & chart
Loading TradingView…
NASDAQ:XTLB on TradingView ↗In the news
Recent filings
Show 5 more recent filings
Financials
FY 2024 · USDSource
Source
Source
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Profit or LossUSD | -1,027,000Source | -1,782,000Source | -1,348,000Source | 435,000Source |
| Additional Financial Items | ||||
| AdjustmentsForDecreaseIncreaseInTradeAccountReceivableUSD | 39,000Source | — | — | — |
| AdjustmentsForFinanceCostsUSD | 14,000Source | 27,000Source | — | — |
| AdjustmentsForIncreaseDecreaseInTradeAccountPayableUSD | 208,000Source | 19,000Source | -44,000Source | -23,000Source |
| AdjustmentsForSharebasedPaymentsUSD | 264,000Source | 3,000Source | 14,000Source | 37,000Source |
| GeneralAndAdministrativeExpenseUSD | 1,590,000Source | 734,000Source | 850,000Source | 1,001,000Source |
| GoodwillUSD | 3,193,000Source | — | — | — |
| RepaymentsOfBorrowingsClassifiedAsFinancingActivitiesUSD | 13,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cost of Goods and Services Sold | — | — | — | — |
| Total RevenueUSD | 451,000Source | — | — | — |
| Additional Financial Items | ||||
| AverageEffectiveTaxRatenumber | — | — | 0.23Source | — |
| BasicEarningsLossPerShareUSD per share | -0Source | -0Source | -0Source | 0Source |
| DeferredTaxExpenseIncomeUSD | -130,000Source | — | — | — |
| DeferredTaxExpenseIncomeRecognisedInProfitOrLossUSD | 130,000Source | — | — | — |
| DilutedEarningsLossPerShareUSD per share | -0Source | -0Source | -0Source | 0Source |
| EmployeeBenefitsExpenseUSD | 605,000Source | 243,000Source | 276,000Source | 276,000Source |
| ExpenseFromSharebasedPaymentTransactionsWithEmployeesUSD | — | — | 14,000Source | 37,000Source |
| FinanceCostsUSD | — | — | 1,558,000Source | 21,000Source |
| FinanceIncomeUSD | 1,127,000Source | 41,000Source | 1,090,000Source | 1,487,000Source |
| GeneralAndAdministrativeExpenseUSD | 1,590,000Source | 734,000Source | 850,000Source | 1,001,000Source |
| GrossProfitUSD | 3,000Source | — | — | — |
| IncomeTaxExpenseContinuingOperationsUSD | -130,000Source | — | — | — |
| InterestExpenseUSD | 28,000Source | — | — | — |
| OtherFinanceCostUSD | 112,000Source | 36,000Source | 27,000Source | 21,000Source |
| PostemploymentBenefitExpenseDefinedContributionPlansUSD | — | — | — | 0Source |
| ProfessionalFeesExpenseUSD | — | — | 291,000Source | 381,000Source |
| ProfitLossBeforeTaxUSD | -1,157,000Source | -1,782,000Source | — | — |
| ProfitLossFromOperatingActivitiesUSD | -2,172,000Source | -765,000Source | -880,000Source | -1,031,000Source |
| ResearchAndDevelopmentExpenseUSD | 98,000Source | 31,000Source | 30,000Source | 30,000Source |
| RevenueFromInterestUSD | 34,000Source | 41,000Source | — | — |